ADARx Pharmaceuticals, Inc.
ADRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802369
In the last 90 days, ADARx Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $44.4M in total
- 3
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ADRX, Q2 2026
No superinvestor reported holding ADRX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by ADARx Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 (view filing)5:29 PM ET | Sep 28 | 2 days | Chimovits ErezDirector | PPurchase | +61.5K | $17.00 | +$1.05M | +0.7%9.29M after | |
| Sep 30, 2026 (view filing)5:25 PM ET | Sep 28 | 2 days | Gordon Carl LDirector, 10% Owner | PPurchase | +950.0K | $17.00 | +$16.1M | New position588.2K after | 3 lotsDuplicate filing |
| Sep 30, 2026 (view filing)5:23 PM ET | Sep 28 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +950.0K | $17.00 | +$16.1M | New position588.2K after | 3 lots |
| Sep 29, 2026 (view filing)9:45 PM ET | Sep 28 | 1 day | Sr One Capital Management, LLC10% Owner | PPurchase | +1.60M | $17.00 | +$27.2M | New position592.6K after | 3 lotsDuplicate filing |
| Sep 29, 2026 (view filing)9:43 PM ET | Sep 28 | 1 day | George SimeonDirector, 10% Owner | PPurchase | +1.60M | $17.00 | +$27.2M | New position592.6K after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in ADARx Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding ADRX in 13F filings for Q2 2026.